Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020;27(4):329-335.
doi: 10.5603/CJ.2020.0108.

The legacy of ISCHEMIA

Umberto Ianni  1 , Francesco Radico  1 , Fabrizio Ricci  2 , Matteo Perfetti  3 , Federico Archilletti  1 , Giulia Renda  1 , Nicola Maddestra  3 , Sabina Gallina  2 , Marco Zimarino  4
Affiliations
Editorial

The legacy of ISCHEMIA

Umberto Ianni et al. Cardiol J. 2020.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared

Figures

None
Umberto Ianni, MD and Marco Zimarino, MD, PhD
Figure 1
Figure 1
Clinical endpoints differences between treatment groups across a 5-year follow-up and relative estimated difference (95% confidence interval [CI]); A. Primary composite outcome; B. Spontaneous myocardial infarction (MI).
Figure 2
Figure 2
Effect of the invasive strategy on symptoms, estimated as the mean difference of invasive versus conservative strategy on Seattle Angina Questionnaire (SAQ) summary scores, according to baseline angina burden during 36 month follow-up.
See this image and copyright information in PMC

Comment on

  • Initial Invasive or Conservative Strategy for Stable Coronary Disease.
    Maron DJ, Hochman JS, Reynolds HR, Bangalore S, O'Brien SM, Boden WE, Chaitman BR, Senior R, López-Sendón J, Alexander KP, Lopes RD, Shaw LJ, Berger JS, Newman JD, Sidhu MS, Goodman SG, Ruzyllo W, Gosselin G, Maggioni AP, White HD, Bhargava B, Min JK, Mancini GBJ, Berman DS, Picard MH, Kwong RY, Ali ZA, Mark DB, Spertus JA, Krishnan MN, Elghamaz A, Moorthy N, Hueb WA, Demkow M, Mavromatis K, Bockeria O, Peteiro J, Miller TD, Szwed H, Doerr R, Keltai M, Selvanayagam JB, Steg PG, Held C, Kohsaka S, Mavromichalis S, Kirby R, Jeffries NO, Harrell FE Jr, Rockhold FW, Broderick S, Ferguson TB Jr, Williams DO, Harrington RA, Stone GW, Rosenberg Y; ISCHEMIA Research Group. Maron DJ, et al. N Engl J Med. 2020 Apr 9;382(15):1395-1407. doi: 10.1056/NEJMoa1915922. Epub 2020 Mar 30. N Engl J Med. 2020. PMID: 32227755 Free PMC article. Clinical Trial.

References

    1. Maron D, Hochman J, Reynolds H, et al. Initial invasive or conservative strategy for stable coronary disease. N Engl J Med. 2020;382(15):1395–1407. doi: 10.1056/nejmoa1915922. - DOI - PMC - PubMed
    1. Spertus J, Jones P, Maron D, et al. Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease. N Engl J Med. 2020;382(15):1408–1419. doi: 10.1056/nejmoa1916370. - DOI - PMC - PubMed
    1. Boden WE, O’Rourke RA, Teo KK, et al. COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15):1503–1516. doi: 10.1056/NEJMoa070829. - DOI - PubMed
    1. Al-Lamee R, Thompson D, Dehbi HM, et al. ORBITA investigators. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. Lancet. 2018;391(10115):31–40. doi: 10.1016/S0140-6736(17)32714-9. - DOI - PubMed
    1. Maron DJ, Hochman JS, O’Brien SM, et al. ISCHEMIA Trial Research Group. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design. Am Heart J. 2018;201:124–135. doi: 10.1016/j.ahj.2018.04.011. - DOI - PMC - PubMed